The Structure and Functions of PRMT5 in Human Diseases

被引:44
|
作者
Motolani, Aishat [1 ]
Martin, Matthew [1 ]
Sun, Mengyao [1 ]
Lu, Tao [1 ,2 ,3 ,4 ]
机构
[1] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA
[2] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA
[3] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA
[4] Indiana Univ Sch Med, Indiana Univ, Melvin & Bren Simon Comprehens Canc Ctr, Indianapolis, IN 46202 USA
来源
LIFE-BASEL | 2021年 / 11卷 / 10期
关键词
PRMT5; cancer; cardiovascular disease; neurodegenerative diseases; diabetes; inflammation; PROTEIN ARGININE-METHYLTRANSFERASE; GENE-EXPRESSION; METHYLATION; PHOSPHORYLATION; TARGET; CELLS; DIMETHYLATION; INHIBITION; COMPLEXES; MAINTAIN;
D O I
10.3390/life11101074
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Since the discovery of protein arginine methyltransferase 5 (PRMT5) and the resolution of its structure, an increasing number of papers have investigated and delineated the structural and functional role of PRMT5 in diseased conditions. PRMT5 is a type II arginine methyltransferase that catalyzes symmetric dimethylation marks on histones and non-histone proteins. From gene regulation to human development, PRMT5 is involved in many vital biological functions in humans. The role of PRMT5 in various cancers is particularly well-documented, and investigations into the development of better PRMT5 inhibitors to promote tumor regression are ongoing. Notably, emerging studies have demonstrated the pathological contribution of PRMT5 in the progression of inflammatory diseases, such as diabetes, cardiovascular diseases, and neurodegenerative disorders. However, more research in this direction is needed. Herein, we critically review the position of PRMT5 in current literature, including its structure, mechanism of action, regulation, physiological and pathological relevance, and therapeutic strategies.</p>
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Prmt5 differentiates developmental vs regenerative myogenesis
    Zhang, Ting
    Braun, Thomas
    Zhou, Yonggang
    ONCOTARGET, 2015, 6 (34) : 35153 - 35154
  • [42] Flavokawain A is a natural inhibitor of PRMT5 in bladder cancer
    Shuangjie Liu
    Zhuonan Liu
    Chiyuan Piao
    Zhe Zhang
    Chuize Kong
    Lei Yin
    Xi Liu
    Journal of Experimental & Clinical Cancer Research, 41
  • [43] Prmt5: a guardian of the germline protects future generations
    Berrens, Rebecca V.
    Reik, Wolf
    EMBO JOURNAL, 2015, 34 (06): : 689 - 690
  • [44] PRMT5 INHIBITION SENSITIZES GLIOBLASTOMA NEUROSPHERES TO TEMOZOLOMIDE
    Rivas, Sarah
    Rivera-Caraballo, Kimberly
    Murphy, Sara
    Otani, Yoshihiro
    Shelbourn, Allison
    Ampie, Leo
    Maric, Dragan
    Walbridge, Stuart
    Shah, Ashish
    Yan, Yuanqing
    Yoo, Young
    Heiss, John
    Kaur, Balveen
    Banasavadi-Siddegowda, Yeshavanath
    NEURO-ONCOLOGY, 2022, 24 : 226 - 227
  • [45] PRMT5 modulates the metabolic response to fasting signals
    Tsai, Wen-Wei
    Niessen, Sherry
    Goebel, Naomi
    Yates, John R., III
    Guccione, Ernesto
    Montminy, Marc
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (22) : 8870 - 8875
  • [46] Role of PRMT5 in bladder cancer: a comprehensive study
    Ma, Yingxin
    Zhong, Yucheng
    Huang, Weiren
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (02) : 491 - 498
  • [47] CELL SIGNALLING PRMT5 restricts ERK activity
    Wrighton, Katharine H.
    NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2011, 12 (11) : 689 - 689
  • [48] PRMT5 Is A New Epigenetic Regulator In Cardiovascular Disease
    Merkel, Tobias S.
    Hassel, David
    Krueger, Marcus
    Weichenhan, Dieter
    Plass, Christoph
    Backs, Johannes
    CIRCULATION RESEARCH, 2013, 113 (04)
  • [49] PRMT5 inhibition disrupts splicing and stemness in glioblastoma
    Patty Sachamitr
    Jolene C. Ho
    Felipe E. Ciamponi
    Wail Ba-Alawi
    Fiona J. Coutinho
    Paul Guilhamon
    Michelle M. Kushida
    Florence M. G. Cavalli
    Lilian Lee
    Naghmeh Rastegar
    Victoria Vu
    María Sánchez-Osuna
    Jasmin Coulombe-Huntington
    Evgeny Kanshin
    Heather Whetstone
    Mathieu Durand
    Philippe Thibault
    Kirsten Hart
    Maria Mangos
    Joseph Veyhl
    Wenjun Chen
    Nhat Tran
    Bang-Chi Duong
    Ahmed M. Aman
    Xinghui Che
    Xiaoyang Lan
    Owen Whitley
    Olga Zaslaver
    Dalia Barsyte-Lovejoy
    Laura M. Richards
    Ian Restall
    Amy Caudy
    Hannes L. Röst
    Zahid Quyoom Bonday
    Mark Bernstein
    Sunit Das
    Michael D. Cusimano
    Julian Spears
    Gary D. Bader
    Trevor J. Pugh
    Mike Tyers
    Mathieu Lupien
    Benjamin Haibe-Kains
    H. Artee Luchman
    Samuel Weiss
    Katlin B. Massirer
    Panagiotis Prinos
    Cheryl H. Arrowsmith
    Peter B. Dirks
    Nature Communications, 12
  • [50] PRMT5, a Novel Epigenetic Target in Lung Cancers
    Otterson, G. A.
    Wu, X.
    Welliver, M.
    Sharma, S.
    Shilo, K.
    Hitchcock, C.
    Li, C.
    Baiocchi, R.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 171 - 171